The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The value of the accelerated approval pathway: real-world outcomes associated with reducing the time between innovations

Published:2024-01-23 Issue:16 Volume:20 Page:1099-1110
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Wong William¹^ORCID,Kowal Stacey¹^ORCID,To Tu My¹^ORCID,Patel Achal¹,Veenstra David²³^ORCID,Garrison Louis²⁴^ORCID,Li Meng⁵^ORCID

Affiliation:

1. Genentech, Inc., South San Francisco, CA 94080, USA

2. Department of Pharmacy, University of Washington, Seattle, WA 98195, USA

3. Curta, Inc., Seattle, WA 98116, USA

4. VeriTech Corporation, Mercer Island, WA 98040, USA

5. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Funder

Genentech, Inc.

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/fon-2023-0514

Reference30 articles.

1. Contributions Of Public Health, Pharmaceuticals, And Other Medical Care To US Life Expectancy Changes, 1990-2015

2. US Food and Drug Administration (FDA). New drugs at FDA: CDER's new molecular entities and new therapeutic biological products. www.fda.gov/drugs/development-approval-process-drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products (13 January 2023).

3. The Effect of Advances in Lung-Cancer Treatment on Population Mortality

4. Spending On Targeted Therapies Reduced Mortality In Patients With Advanced-Stage Breast Cancer

5. Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP